Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation

Liu Ling; Zhang Chiqian; Hu Yanyan; Zhou Li; Tan Qinghua

首页> 外文期刊>Clinics and research in hepatology and gastroenterology >Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation

【24h】

Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation

机译：细菌性肝硬化大鼠肠内toll样受体4和nod样受体家族含3个蛋白的内源性途径的改变

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Bacterial translocation (BT) plays a vital role in the development of liver cirrhosis (LC); however, little is known regarding the role of gut innate immunity in cirrhosis. Aims: To observe the influence of BT on multiple vital organs in LC and changes in the gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation.

机译：背景：细菌易位（BT）在肝硬化（LC）的发展中起着至关重要的作用。然而，关于肠道固有免疫在肝硬化中的作用知之甚少。目的：观察BT对肝硬化大鼠细菌性易位的LC的多个重要器官的影响以及肠道toll样受体4和nod样受体家族含3个固有结构的内源性途径的变化。

著录项

来源
《Clinics and research in hepatology and gastroenterology》 |2016年第5期|共9页
作者
Liu Ling; Zhang Chiqian; Hu Yanyan; Zhou Li; Tan Qinghua;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation [J] . Liu Ling, Zhang Chiqian, Hu Yanyan, Clinics and research in hepatology and gastroenterology . 2016,第5期

机译：细菌性肝硬化大鼠肠内toll样受体4和nod样受体家族含3个蛋白的内源性途径的改变
2. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome [J] . Jian Hu, Yun Zhu, Jian-Zhong Zhang, 中华医学杂志（英文版） . 2017,第005期

机译：穆克氏综合征中NOD样受体家族蛋白结构域3的蛋白结构域的新型突变。
3. SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)–Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation [J] . Xin Tang, Lihong Pan, Shuang Zhao, Circulation: An Official Journal of the American Heart Association . 2020,第12期

机译：通过TLR3（Toll样受体3）介导的RIP3（受体相互作用蛋白激酶3）和NLRP3（含有3个）炎症组的NOR样受体吡林结构域的NLRP3（含有3）炎症组的NLRP3（含有3）炎症组活化的NLRP3（含有3）氨基激活的NLRP3（含有3）活化
4. Dendritic cell targeted nano-vaccine delivery system engineered from a plant polymer based Toll-Like Receptor-4 agonist Inulin Acetate [C] . Siddharth S. Kesharwani, Mrigendra K.S. Rajput, Sunny Kumar, Society for Biomaterials annual meeting and exposition . 2017

机译：树突状细胞靶向纳米疫苗递送系统，由基于植物聚合物的Toll-Like Receptor-4激动剂菊糖乙酸酯设计而成
5. Innate immune defense mechanisms in the lung upon bacterial infection: Submucosal glands, antimicrobial peptides and Toll-like receptors. [D] . Wang, Xiaorong. 2002

机译：细菌感染后肺部的先天免疫防御机制：粘膜下腺，抗菌肽和Toll样受体。
6. Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice [O] . Yinzhi Cheng, Shuai Li, Muzi Wang, 1923

机译：过氧化物酶体增殖物激活受体γ（PPARγ）激动剂罗格列酮通过抑制Toll样受体2（TLR2）/ Nod样受体与含3（NLRP3）炎性小鼠哮喘小体的活化来改善气道炎症。
7. Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice [O] . Yinzhi Cheng, Shuai Li, Muzi Wang, 2018

机译：过氧化物体增殖剂活化受体γ（PPARγ）激动剂rosiglitazone通过抑制含有3（NLRP3）炎性菌根活化的吡喃结构域中的吡喃结构域（NLRP3）炎症小鼠中的吡林结构域来改善气道炎症

Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation

摘要

著录项

相似文献

相关主题

期刊订阅